Section Arrow
Quote
TLSA.NASDAQ
- Tiziana Life Sciences Ltd
Quotes are at least 15-min delayed:2025/06/06 01:25 EDT
Last
 1.41
-0.02 (-1.40%)
Day High 
1.5 
Prev. Close
1.43 
1-M High
1.78 
Volume 
157.80K 
Bid
1.4
Ask
1.5
Day Low
1.39 
Open
1.45 
1-M Low
1.22 
Market Cap 
167.09M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.42 
20-SMA 1.46 
50-SMA 1.25 
52-W High 1.91 
52-W Low 0.6295 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.11/-0.09
Enterprise Value
167.09M
Balance Sheet
Book Value Per Share
0.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.0393-0.0068-14.75%-- 
CLRBCellectar Biosciences0.399201-0.062499-13.54%-- 
RXRXRecursion Pharmaceuticals4.56-0.35-7.13%-- 
GLYCGlycoMimetics0.1994-0.0106-5.05%-- 
SCNIScinai Immunotherapeutics Ltd.3.07+0.55+21.83%1.21PE
Quotes are at least 15-min delayed：2025/06/06 01:25 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.